Professional Research on Elan Corp. and Delcath Systems - Keys to Success in Specialized Pharmaceuticals JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 08/02/10 -- www.wallstreetequityresearch.com gives shareholders valuable insight on drug delivery stocks Elan Corp. plc (NYSE: ELN) and Delcath Systems Inc. (NASDAQ: DCTH). Sign up today at www.wallstreetequityresearch.com to receive free research reports on these equities. Specialized pharmaceutical companies operate in an exceptionally high risk and tumultuous industry. The successes can be high-flying but obstacles and hindrances can be unforeseen and devastating. www.wallstreetequityresearch.com is a specialized website where investors can have specific access to free reports drug delivery industry; traders looking for analyst opinions on Elan Corp. plc, Delcath Systems Inc. and other companies in this industry are welcomed to sign up for a free one year membership at http://www.wallstreetequityresearch.com/. Smaller, more specialized pharmaceutical companies are less likely to absorb losses. Ireland-based Elan Corp. Plc recently paid $206.3 to settle a U.S government investigation into an epilepsy drug. The company posted $68.2 million in net debt last year and this recent settlement nearly triples that. Traders can get direct and free access to today's full report on Elan Corp. plc by signing up at http://wallstreetequityresearch.com/August022010ElanCorp.plc(ELN)020810.php. The success of drug trials is exceptionally vital for specialized pharmaceuticals like Delcath Systems Inc. A great deal of capital goes into research and development. The results of clinical trials can lead to long-term ramifications for these companies. Traders can have complimentary access to today's complete research report on Delcath Systems Inc. by signing up at http://wallstreetequityresearch.com/August022010DelcathSystemsInc.(DCTH)020810.p hp. Balanced sales, successful drug trials and lawsuit avoidance are the keys to stability in the specialized pharmaceutical industry these days. Visit us at http://www.wallstreetequityresearch.com/ to understand the catalysts and forces driving or affecting the drug delivery industry in today's economic environment. About Wall Street Equity Research: Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. Contact Person: Edward D. Brooks firstname.lastname@example.org
Professional Research on Elan Corp. and Delcath Systems - Keys
Press spacebar to pause and continue. Press esc to stop.